ASX/ACW (ASX/ACW)

Australian Securities Exchange: ASX/ACW · AUD

A$0.04

+0.00 (+7.5%)· Recorded snapshot

Market cap	165.5M
Revenue (ttm)	12.7M
Net income (ttm)	-15.4M
EPS (ttm)	-A$0.00
Shares out	3.8B
Volume	4,384,477
Beta	0.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.7M
Net income (ttm): -15.4M
EPS (ttm): -A$0.00
Market cap: 165.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-77.5

P25 n/aP50 n/aP75 n/a

ROIC-40.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/ACW indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

AUD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-25
Employees	6
Enterprise value	AUD 153.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1999
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000ACW3
Last earnings date	2026-02-19
Last refreshed	2026-10-29
Last stock split date	2013-12-03
Last stock split type	Reverse
Market cap	AUD 165.5M
Next earnings date	2026-11-25
Price	AUD 0.04
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/ACW
Website	https://actinogen.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-10.73%
EV/Sales	11.2x
FCF / EV yield	-12.38%
FCF yield	-11.42%
Industry forward P/E	28.82x
P/B ratio	7.2x
P/S ratio	12.14x
Price / tangible book value	7.73x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-121.82%
EBITDA margin	-119.15%
Gross margin	100%
Operating margin	-121.82%
Pretax margin	-121.35%
Profit margin	-121.35%
Profit per employee	AUD -2.6M
Revenue per employee	AUD 2.1M
ROA	-35.71%
ROA (5Y)	-37.45%
ROCE	-71.94%
ROE	-77.46%
ROE (5Y)	-68.68%
ROIC	-40.41%
SBC / revenue	13.6%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	2
Gross profit growth	130.87%
Gross profit growth (Q)	96.73%
Gross profit growth 3Y	37.38%
Gross profit growth 5Y	44.9%
Net income growth quarters	1
Net income growth years	0
Revenue growth	130.87%
Revenue growth (Q)	96.73%
Revenue growth (QoQ)	476.25%
Revenue growth 10Y	12.36%
Revenue growth 3Y	37.38%
Revenue growth 5Y	44.9%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -9,293
Depreciation and amortization	AUD 338,308
EBIT	AUD -15.4M
EBITDA	AUD -15.1M
EPS	AUD -0.00
FCF per share	AUD -0.00
Financing cash flow	AUD 17.8M
Free cash flow	AUD -17.6M
Free cash flow minus SBC	AUD -19.3M
Gross profit	AUD 12.7M
Investing cash flow	AUD -9,293
Net borrowing	AUD 1.1M
Net cash flow	AUD 230,707
Net income	AUD -15.4M
Operating cash flow minus SBC	AUD -19.3M
Operating income	AUD -15.4M
Revenue	AUD 12.7M
Stock-based compensation	AUD 1.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.76
Book value per share	AUD 0.01
Debt / equity	0.22
Interest coverage	-33.14
Long-term assets	AUD 1.6M
Long-term liabilities	AUD 87,442
Net cash (debt)	AUD 12M
Net cash / market cap	7.76%
Net cash growth	-9.73%
Net debt / equity	-0.56
Piotroski F-Score	1
Property, plant and equipment	AUD 172,808
Shareholders' equity	AUD 21.4M
Tangible book value	AUD 19.9M
Tangible book value per share	AUD 0.01
Total assets	AUD 29.6M
Total cash	AUD 16.7M
Total debt	AUD 4.8M
Total liabilities	AUD 8.2M
WACC	8.77%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	AUD 27.9M
Current liabilities	AUD 8.1M
Current ratio	3.45
Net working capital	AUD 7.8M
Quick ratio	3.44
Working capital	AUD 19.8M
Working capital turnover	0.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.82%
Shareholder yield	-11.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	6.25%
10Y return CAGR	1.36%
10Y total return	14.44%
150-day SMA	AUD 0.04
15Y price change	-15%
15Y return CAGR	-0.59%
15Y total return	-8.45%
1D price change	7.5%
1M price change	-26.72%
1M total return	-26.72%
1W price change	-9.57%
1W total return	-9.57%
1Y price change	25%
1Y return CAGR	25.02%
1Y total return	25%
20-day SMA	AUD 0.05
200-day SMA	AUD 0.04
3M price change	3.66%
3M total return	3.66%
3Y price change	165.63%
3Y return CAGR	39.12%
3Y total return	169.31%
50-day SMA	AUD 0.05
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 0.07
52-week high date	2026-01-07
52-week low	AUD 0.03
52-week low date	2026-06-30
5Y price change	-68.52%
5Y return CAGR	-19.78%
5Y total return	-66.77%
6M price change	-5.56%
6M total return	-5.56%
All-time high	AUD 1.05
All-time high date	2007-10-16
All-time low	AUD 0.01
All-time low date	2019-09-06
Average true range (ATR)	AUD 0.00
Average volume	5M
Beta (1Y)	-0
Beta (2Y)	0.29
Beta (5Y)	0.83
Change from 52-week high	-40.28%
Change from 52-week low	38.71%
Change from all-time high	-95.95%
Change from all-time low	507.14%
Change from open	4.88%
Day's gap	2.5%
Dollar volume	AUD 188,533
High price	AUD 0.04
Low price	AUD 0.04
Monthly RSI	50.67
Open price	AUD 0.04
Position in 52-week range	100%
Previous close	AUD 0.04
Price vs 150-day SMA	-2.75%
Price vs 20-day SMA	-10.53%
Price vs 200-day SMA	-1.85%
Price vs 50-day SMA	-16.67%
Relative volume	0.87
RSI	40.65
Sharpe ratio	0.66
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	0.29
Sortino ratio	1.08
Sortino ratio (3Y)	1.35
Sortino ratio (5Y)	0.52
Volume	4.4M
Weekly RSI	45.6
YTD price change	-30.33%
YTD total return	-30.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Shares change (QoQ)	11.42%
Shares change (YoY)	11.82%
Shares held by insiders	11.97%
Shares held by institutions	2.93%
Shares outstanding	3.8B

Deeper analysis on ASX/ACW

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/ACW report

Is a complete ASX/ACW research report available?

No complete published report is available for asx/ACW (ASX/ACW) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/ACW (ASX/ACW)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/ACW

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/ACW indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/ACW

Frequently asked questions